Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response
Oncolytic virus (OV) treatment may offer a new treatment option for the aggressive brain tumor glioblastoma. Clinical trials testing oncolytic viruses in this patient group have shown promising results, with patients achieving impressive long-term clinical responses. However, the number of responder...
Main Authors: | Eftychia Stavrakaki, Clemens M. F. Dirven, Martine L. M. Lamfers |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/614 |
Similar Items
-
Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
by: Mason J. Webb, et al.
Published: (2023-05-01) -
Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01) -
Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
by: Zhongbing Qi, et al.
Published: (2022-09-01) -
Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma
by: Alisa Ageenko, et al.
Published: (2024-02-01) -
Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme
by: Tanvir Ahmed
Published: (2023-03-01)